Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and how well papaverine hydrochloride and
stereotactic radiation therapy body (SBRT) work in treating patients with non-small cell lung
cancer. Papaverine hydrochloride may help radiation therapy work better by making tumor cells
more sensitive to the radiation therapy. Stereotactic body radiation therapy uses special
equipment to position a patient and deliver radiation to tumors with high precision. This
method can kill tumor cells with fewer doses over a shorter period and cause less damage to
normal tissue. Giving papaverine hydrochloride with SBRT may work in treating patients with
non-small cell lung cancer.